CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, Research & CSO sold 1,755 shares at $38.00 ($66,690)
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $30.07 ($114,418)
- 4 Open-market sale Chief Business Officer sold 75,000 shares at $30.05 ($2,253,885)
- 4/A Insider Changes in Ownership
- 4 Open-market sale Director sold 18,458 shares at an average $28.00 ($516,853)
- 4 Exercise or conversion Chief Medical Officer acquired 8,000 shares (option exercise)
- 4 Other disposition President and CEO disposed of 236,806 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,000,000 shares at $20.00 ($20,000,000)
- 4 Open-market buy Director bought 1,000,000 shares at $20.00 ($20,000,000)
- 4 Open-market buy 10% owner bought 1,000,000 shares at $20.00 ($20,000,000)
- 4 Conversion Director acquired 222,220 shares (conversion)
- 4 Conversion Director acquired 2,005,265 shares (conversion)
- 4 Conversion Director acquired 218,400 shares (conversion)
- 4 Conversion Former 10% Holder acquired 1,666,666 shares (conversion)
- 4 Open-market buy 10% owner bought 500,000 shares at $20.00 ($10,000,000)
Page 23 of 25 · 491 filings